European Journal of Cardiovascular Medicine

Discoveries in regenerative medicine have the potential to revolutionize healthcare by creating new ways to restore and restore function to damaged or sick organs, tissues, or cells. This branch of medicine has increasingly gained prominence due to its potential to offer solutions to conditions previously deemed untreatable [1]. The identification and use of stem cells are pivotal to the domain of regenerative medicine. Due to their intrinsic flexibility and capacity for self-renewal, stem cells have the potential to differentiate into a diverse range of cell types. Their unique and unparalleled quality makes them useful in the realm of regenerative medicine [2].

The field of regenerative medicine has its roots in the middle of the twentieth century. In 1956, a watershed moment occurred in the area when the first bone marrow transplant was successful. This innovative approach facilitated researchers in comprehending the whole therapeutic capacity of stem cells. This incident was crucial, not only as a unique medical accomplishment but also as a catalyst for an entire area of study and clinical implementation [3].

Two major findings brought about a significant transformation in the field of stem cell research. Embryonic stem cells, due to their pluripotent characteristics, offered new opportunities upon their first isolation in 1998. In 2006, induced pluripotent stem cells (iPSCs) were successfully generated, representing a notable achievement. Induced pluripotent stem cells (iPSCs) are a morally better and more adaptable alternative to embryonic stem cells. They are created by reprogramming adult cells to exhibit the same characteristics as embryonic stem cells.

These breakthroughs have expanded the possibilities for study and therapy, greatly widening the range of regenerative medicine [4]. The field has shown considerable promise in addressing a range of diseases and conditions. As an example, there is great promise for the regeneration and repair of damaged hearts thanks to the active exploration of stem cell therapy as a treatment for cardiac illness. In the realm of endocrinology, there is potential for stem cells to play a role in diabetes treatment, possibly providing a means to regenerate insulin-producing cells [5].

One of the most promising areas for stem cell therapy is the treatment of neurological illnesses, including Parkinson's disease. The possibility of replacing damaged or degenerated neurons presents a revolutionary approach to managing these conditions. Furthermore, stem cell integration into tissue engineering has revolutionized the treatment of spinal cord injuries and severe burns, expanding the frontiers of traditional medicine. [6,7,8,]. The therapeutic applications of stem cells extend beyond these examples, encompassing a wide spectrum of conditions, including but not limited to liver diseases, osteoarthritis, and various forms of cancer [9].

The versatility and adaptability of stem cell therapy make it a cornerstone of future medical interventions. Despite these exciting advancements, there are several ethical concerns and obstacles in the regenerative medicine sector [10]. The use of embryonic stem cells, for instance, continues to be a topic of ethical debate, prompting a need for stringent regulatory frameworks. Furthermore, to ensure the safety and efficacy of stem cell therapy in clinical settings, a meticulous and comprehensive strategy is necessary [11].

The domain of regenerative medicine and stem cell treatment is on the verge of seeing rapid and significant expansion. With ongoing research and technological advancements, the next few decades may witness revolutionary changes in how we approach and treat a myriad of diseases. The convergence of biotechnology, nanotechnology, and tissue engineering is likely to further enhance the capabilities of regenerative medicine, making previously unthinkable treatments a reality.

Regenerative medicine and stem cell therapy represent a paradigm shift in modern healthcare [12]. Their potential to heal and regenerate offers hope for numerous conditions, marking a new era in medical science. As research continues to advance, it is imperative to balance scientific progress with ethical considerations, ensuring that the journey of regenerative medicine continues to be marked by innovation, responsibility, and transformative healing [13].

Classification and Mechanisms of Stem Cells in Regenerative Medicine

Regenerative medicine relies on stem cells, which may be generally divided into pluripotent and somatic (adult) stem cell types. Numerous stem cell types exist, each with its own set of desirable traits and possible uses in healthcare.

Pluripotent Stem Cells

The remarkable capacity of pluripotent stem cells to differentiate into several types of mature cells in the adult body is absolutely astounding. This attribute makes them invaluable in regenerative medicine, offering the potential to create a diverse range of cell types for therapeutic purposes [16]. There are two main categories of pluripotent stem cells:

1. Embryonic Stem Cells (ESCs): Early stem cells (ESCs) can proliferate endlessly without differentiation since they are derived from the blastocyst, an embryo in its early stages before implantation. Their pluripotency allows them to differentiate into any cell type, making them a powerful tool for understanding developmental processes and for potential therapeutic applications [17].

2. Induced Pluripotent Stem Cells (iPSCs): One cutting-edge method for converting adult stem cells to behave more like embryonic stem cells is known as induced pluripotent stem cells (iPSCs). In this process, iPSCs, which are derived from embryonic stem cells (ESCs), gain the capacity to differentiate into several cell types. An important step forward, induced pluripotent stem cells (iPSCs) may generate patient-specific cells without using embryonic stem cells (ESCs), which is a major ethical problem. [18].

Somatic (Adult) Stem Cells

Many bodily tissues and organs may include somatic stem cells, which are also called adult stem cells. These cells, in contrast to pluripotent stem cells, are limited to differentiating into the cell types found in the organ or tissue from which they were first taken. Their inherent ability to mend and regenerate is further enhanced by their uniqueness. Their maintenance and repair of the tissue in which they live is an essential step for the organs' lifetime and functioning, and they play a pivotal part in this process.

Mechanisms of Action in Regeneration

The mechanisms through which stem cells facilitate regeneration and repair are complex and not yet fully understood [19]. However, several key processes have been identified:

Fig-In the treatment of liver diseases, stem cells can aid in repair through multiple mechanisms. They can replace damaged liver cells and offer gene therapy benefits by introducing healthy genes. Additionally, stem cells secrete growth factors and cytokines/chemokines, mitigating liver damage. They also produce extracellular vehicles (EVs) containing restorative biomolecules, contributing to liver regeneration [15].

1. Differentiation into Specific Cell Types: The capacity of stem cells to differentiate into specific cell types is crucial for the regeneration and repair of tissues. As they go through this process, stem cells lose their pluripotent nature and gain a greater capacity for specific differentiation. Eventually, they differentiate into fully formed cells such as neurons, cardiomyocytes, or cells that produce insulin [20].

2. Secretion of Growth Factors and Cytokines: An important part of stem cells' function in the healing process is the secretion of cytokines and growth factors. Substances like this help cells proliferate, differentiate, and stay alive. Furthermore, they play a part in lowering inflammation and promoting angiogenesis, the process of creating new blood vessels, which is critical for delivering oxygen and nutrients to the tissues that are regenerating [21].

3. Cell-to-Cell Interactions: Stem cells interact with their surrounding environment, including other cell types, the extracellular matrix, and various signaling molecules. Controlling stem cell activities, such as self-renewal and differentiation, relies on these connections. [22].

In summary, the exploration of stem cells, both pluripotent and somatic, has opened new horizons in regenerative medicine. If we want to find treatments that work for a variety of illnesses and injuries, we need to know how these cells work. More and more research in this field could revolutionize the way we detect, treat, and track many different types of health problems [23].

Regenerative medicine, an innovative field at the forefront of healthcare, has made substantial advancements over recent years. Its progress is underpinned by several key technologies and methodologies, each contributing uniquely to its evolution.

Key Technologies and Methodologies in Regenerative Medicine:

Regenerative medicine, a field at the cutting edge of medical science, has seen rapid growth and numerous breakthroughs in recent years. This growth is largely attributed to advancements in several key areas:

1. Tissue Engineering:

One particularly ground-breaking branch of regenerative medicine is tissue engineering. It entails generating or restoring organs and tissues with the use of live cells, often stem cells. This interdisciplinary field brings together biology, chemistry, and engineering to develop synthetic organs and tissue grafts. The aim is to replace or repair damaged tissues, thereby offering solutions for organ failure or severe injuries. Stem cells' versatility makes them an attractive candidate for application in tissue engineering; by differentiating into diverse cell types, they may one day allow for the laboratory growth of organs suitable for transplantation without the danger of rejection [24].

2. Gene Therapy:

One innovative method for treating or preventing illness, particularly genetic problems, is gene therapy, which involves introducing certain genes into a patient's cells. By correcting gene defects directly at their source, gene therapy provides a potentially definitive treatment for various inherited diseases. With the development of CRISPR and other gene editing tools, gene therapy has become much more effective, allowing for more targeted changes to the genome and paving the way for potential genetic treatments for disorders [25].

3. Cell-Based Therapies:

Therapies based on cells, most notably stem cells, are fundamental to regenerative medicine. These cells may be reprogrammed to become the specific cells required for the body to repair and restore damaged tissues and organs. The ability to create induced pluripotent stem cells (iPSCs) from a patient's own cells makes them very adaptable; this opens the door to individualized medical therapies and decreases the likelihood of immunological rejection. This adaptability of stem cells has led to groundbreaking therapies in various fields, from neurology to cardiology [26].

4. Biomaterials:

Biomaterials are engineered substances designed to interact with biological systems for therapeutic or diagnostic applications. These materials are crucial in tissue engineering, where they provide scaffolding to support cell growth and differentiation. Biomaterials can be designed to mimic the natural extracellular matrix, providing an optimal environment for cell growth and integration into host tissues [27].

Notable Successes:

- Heart Disease Treatment with Stem Cells: A landmark clinical trial has demonstrated the potential of stem cells in treating heart disease. Patients with heart failure underwent a procedure where stem cells extracted from their own bone marrow were injected into their hearts. This treatment showed a notable improvement in heart function and a significant reduction in the risk of death [28].

- Stem Cell Therapy for Spinal Cord Injuries: Clinical experiments involving the use of stem cells produced from bone marrow to treat spinal cord injury also revealed a significant improvement. This approach has shown promise in enhancing motor function and reducing the need for medication, marking a significant step forward in neuroregenerative therapy [29].

These achievements underscore the transformative impact of regenerative medicine. As the field continues to evolve, driven by relentless research and technological innovations, it holds immense promise in tackling some of the most challenging medical conditions. The future of regenerative medicine not only lies in treating diseases but also in offering hope for revolutionary therapies where conventional medicine has been limited, potentially reshaping the landscape of healthcare and treatment modalities [30].

In summary, regenerative medicine stands at the cusp of a new era in medical treatment. Its integration of various technologies and methodologies paves the way for novel therapies that could fundamentally change our approach to healing and disease management. This dynamic field promises not only to repair but also to rejuvenate and replace damaged tissues and organs, potentially altering the landscape of healthcare in profound ways.

Clinical Applications: Applications: Clinical Applications:

Regenerative medicine and stem cell therapy are rapidly advancing fields with significant applications in various medical areas, including wound healing, organ transplantation, and neurological disorders. The versatility of these therapies lies in their ability to address a broad spectrum of medical conditions, demonstrating the potential to transform healthcare [31].

Mesenchymal Stem Cells (MSCs) in Regenerative Medicine

A key player in regenerative medicine is Mesenchymal Stem Cells (MSCs). These cells are highly valued due to their multipotent differentiation abilities, allowing them to become various cell types. They also exhibit remarkable self-renewal capacity and long-term proliferation ex vivo. MSCs are known for their paracrine potentials - they secrete bioactive molecules that exert therapeutic effects. Moreover, their immunoregulatory effects make them suitable for applications where immune responses need modulation, such as in organ transplantation [32].

Clinical Trials and Applications

As per ClinicalTrials.gov, there are over 5,000 registered clinical trials involving stem cell therapies, emphasizing the widespread interest in this field. These trials span a range of organs, including the lung, kidney, heart, and liver. A significant focus of these trials is on assessing the safety and effectiveness of stem cell therapies, a critical step towards their widespread clinical adoption [33].

Specific Applications in Clinical Trials:

1. Treatment of Keratoconus with MSCs: A recent study highlighted the use of MSCs in treating keratoconus, a corneal disorder. Transplanting these cells into the corneal stroma showed improved vision and corneal parameters, presenting a promising therapeutic option without notable side effects [34].

2. Stem Cells in Immune Modulation and Neoangiogenic Regeneration: Cellular therapies, including stem cells, immune cells, and extracellular vehicles (EVs), show potential in modulating inflammatory immune responses. This approach is particularly relevant in treating diseases with an inflammatory component, such as damaged grafts or COVID-19. The neoangiogenic regeneration capability of these therapies can be crucial in repairing diseased organs and tissues [35].

The Future of Regenerative Medicine and Stem Cell Therapy

Stem cell treatment has a bright future in medicine, according to the findings of many clinical studies. These therapies are not just limited to treating diseases but also offer potential in enhancing organ function and overall patient outcomes. Nevertheless, regenerative medicine is a rapidly developing subject, and further research is necessary to fully realize its promise. Challenges such as ensuring safety, understanding long-term effects, and ethical considerations are areas that need continued focus [36].

Finally, cutting-edge fields like stem cell therapy and regenerative medicine have the potential to completely alter the way many different types of medicine are practiced. The ongoing clinical trials and research are pivotal in shaping the future of these therapies, potentially leading to groundbreaking treatments for a myriad of diseases and disorders [37].

Ethical, Legal, and Social Implications (ELSI):

Although stem cell therapy and regenerative medicine have enormous potential as game-changing medical therapies, they are also areas with many social, legal, and ethical questions (ELSI). Understanding these facets is crucial for anyone delving into this area of study [38].

Ethical Considerations

There is a wide range of complex ethical issues surrounding stem cell treatment and regenerative medicine. Among the most divisive moral issues is the potential use of embryonic stem cells. Since removing these cells usually necessitates killing an embryo, there are strong moral arguments over the embryo's place in society. The potential for genetic modification in stem cell therapies also raises concerns, especially about the long-term effects and unintended consequences of altering the human genome [39].

Another area of ethical contention is the possibility of creating chimeras, organisms that have cells from more than one species. This possibility, while offering substantial scientific insights, raises profound questions about species identity and integrity. Furthermore, there is still much controversy around the use of stem cells obtained from aborted babies, which intersects with larger ethical discussions surrounding abortion and the research using fetal material [40].

Legal and Regulatory Landscape

The regulatory framework for regenerative medicine and stem cell therapy varies significantly across different countries, reflecting diverse ethical perspectives and healthcare policies.

- India's Regulatory Framework: In India, the regulatory environment for regenerative medicine is somewhat loosely structured, relying largely on indefinite guidelines. This lack of clear-cut regulations can lead to ambiguities in the implementation and oversight of stem cell therapies, impacting both research and clinical applications [41].

- United States Regulatory Framework: U.S. stem cell therapy regulation is more well-established and is carried out by the Food and Drug Administration (FDA). Therapeutic uses of stem cells are considered biological products in the United States. Because of this categorization, every stem cell product seeking clinical approval must undergo extensive research to guarantee safety and effectiveness. The FDA's stringent regulations aim to safeguard patients from unproven and potentially harmful treatments, balancing innovation with patient safety [42].

Challenges and limitation

Regenerative medicine and stem cell therapy, fields replete with transformative potential, are currently navigating a landscape of significant challenges and limitations that must be addressed to fully realize their healthcare revolutionizing capabilities [43]

Technical Challenges

The selection of appropriate stem cells for therapeutic applications presents a major technical hurdle. Each stem cell type, from embryonic to adult stem cells, possesses unique properties and limitations. Finding the most suitable type for each specific medical application requires a deep understanding of these characteristics. Furthermore, genetic instability in stem cells remains a concern, as it may lead to undesirable outcomes, including tumorigenicity or abnormal differentiation [44].

The fact that our knowledge of how stem cells work at specific locations is still limited presents another technical hurdle. Although a lot has been learned about these cells and how they work, there are still some mysteries, especially about their molecular and cellular interactions with the host environment and how they impact it.

Ethical Concerns

Ethical issues continue to be at the forefront of debates in regenerative medicine. For example, the killing of embryos for the purpose of using embryonic stem cells creates serious ethical concerns. Additionally, the potential for genetic modification in stem cell therapy sparks concerns about the long-term effects and ethical implications of altering human genetics. The possibility of creating chimeras, organisms with cells from more than one species, further complicates the ethical landscape, challenging our traditional understanding of species boundaries [45].

Logistical and Economic Challenges

The manufacturing and processing of stem cells for therapeutic use present logistical challenges. Scaling up production while maintaining cell quality and viability is a complex task that requires advanced technological solutions. Economically, the high costs associated with stem cell therapies can be a barrier to their widespread adoption and accessibility [46].

Regulatory Landscape

The regulatory framework for stem cell therapies varies globally, adding another layer of complexity. In countries like India, the regulatory guidelines for regenerative medicine are still evolving, leading to uncertainties in implementation and oversight. In contrast, the United States has established a more rigorous regulatory framework under the FDA, where stem cell therapies are treated as biological products and subjected to extensive testing and clinical trials. These differing regulatory environments affect how therapies are developed, tested, and brought to market [47].

Current Limitations and Areas for Improvement

Despite the progress in regenerative medicine, several limitations persist. For instance, many stem cell-based therapies have yet to fulfill regulatory requirements fully, and few have achieved commercialization. Moreover, the complete understanding of the mode of action of these therapies at their target sites remains elusive.

Improvements are needed in technology development to enhance the cost-efficiency, purity, and overall quality of manufactured products. Additionally, better model systems are required for preclinical testing to predict clinical outcomes more accurately [48].

Future Direction

The fields of regenerative medicine and stem cell therapy are advancing at a fast pace, which bodes well for the future of medical treatment and patient care. The incorporation of personalized medicine is a promising area for enhancing the efficacy and safety of medications. This approach involves creating therapies that are specific to each patient's genetic profile. There has been encouraging progress in this area with the development of induced pluripotent stem cells (iPSCs), which provide personalized therapy options without posing the same ethical concerns as embryonic stem cells [49].

It is believed that developments in nanotechnology and bioengineering will be crucial in improving the effectiveness of regenerative treatments. These advancements in technology have the potential to enhance stem cell distribution and integration into injured tissues, as well as to facilitate the development of more advanced tissue scaffolds that can direct the regeneration of intricate organs and tissues. There will likely be an increase in the number of illnesses treated using stem cell therapies in the coming years. Regenerative medicine has great promise for the treatment of diseases with few existing choices, including neurological illnesses, catastrophic traumas, and uncommon genetic diseases. Furthermore, there is a dire lack of organ donors, but there is hope in the emerging area of organ regeneration [50].

Furthermore, there will be ongoing changes to the ethical and regulatory environment. Emerging to strike a balance between innovation and ethical responsibility, new rules and regulations are expected to be proposed as the public and scientific community try to make sense of the consequences of these enhanced treatments. Yet, there are still many obstacles to overcome, such as figuring out how stem cell treatments will affect people in the long run, making sure they can afford them, and overcoming the technological difficulties in cell manipulation and tissue creation. It will need a combined effort by researchers, medical professionals, ethicists, and lawmakers to overcome these obstacles [51].

There is hope for a bright future in regenerative medicine and stem cell treatment, which may completely alter the way many injuries and illnesses are addressed. To fully realize the promise of these revolutionary disciplines, ongoing study, technical innovation, and ethical concerns are essential [52].

Finally, in a new age of healthcare, regenerative medicine and stem cell treatment are leading the charge, with revolutionary promise to cure many injuries and illnesses that were before thought to have no hope of recovery. New methods for treating complex medical conditions, including heart problems and neurological diseases, have arisen as a result of advances in tissue engineering, gene therapy, and the use of mesenchymal stem cells. Having said that, there will be obstacles along the way. There is a need for thoughtful discussion and debate on ethical issues, especially those pertaining to embryonic stem cell research and the possibility of genetic modification. It is already difficult to get these treatments from the lab to the clinic due to the differing regulatory frameworks in each country. Still, with continuous research leading to better and more efficient therapies, regenerative medicine and stem cell therapy have a promising future. The field's ongoing development gives hope for regeneration and healing in areas where it was previously believed to be impossible, and it has the potential to completely transform medical therapy. Scientific and technical progress are essential, but a well-rounded strategy that takes into account the project's ethical, legal, and societal ramifications is also necessary for its success.

1. Mead B., Berry M., Logan A., Scott R. A. H., Leadbeater W., Scheven B. A. Stem cell treatment of degenerative eye disease. Stem Cell Research. 2015;14(3):243–257. doi: 10.1016/j.scr.2015.02.003. 
2. Kessler M., Hoffmann K., Brinkmann V., et al. The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nature Communications. 2015;6, article 8989 doi: 10.1038/ncomms9989. 
3. Nagata H., Ii M., Kohbayashi E., Hoshiga M., Hanafusa T., Asahi M. Cardiac adipose-derived stem cells exhibit high differentiation potential to cardiovascular cells in C57BL/6 mice. Stem Cells Translational Medicine. 2016;5(2):141–151. doi: 10.5966/sctm.2015-0083. 
4. Chen L., Qin F., Ge M., Shu Q., Xu J. Application of adipose-derived stem cells in heart disease. Journal of Cardiovascular Translational Research. 2014;7(7):651–663. doi: 10.1007/s12265-014-9585-1. 
5. Steinbach S. K., Husain M. Vascular smooth muscle cell differentiation from human stem/progenitor cells. 2016;101:85–92. doi: 10.1016/j.ymeth.2015.12.004. 
6. Dominici M., Le Blanc K., Mueller I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. 2006;8(4):315–317. doi: 10.1080/14653240600855905. 
7. Sharma A. K., Bury M. I., Marks A. J., et al. A nonhuman primate model for urinary bladder regeneration using autologous sources of bone marrow-derived mesenchymal stem cells. STEM CELLS. 2011;29(2):241–250. doi: 10.1002/stem.568. 
8. Oshima M., Tsuji T. Whole tooth regeneration as a future dental treatment. Advances in Experimental Medicine and Biology. 2015;881:255–269. doi: 10.1007/978-3-319-22345-2_14. 
9. Csaki C., Matis U., Mobasheri A., Ye H., Shakibaei M. Chondrogenesis, osteogenesis and adipogenesis of canine mesenchymal stem cells: a biochemical, morphological and ultrastructural study. Histochemistry and Cell Biology. 2007;128(6):507–520. doi: 10.1007/s00418-007-0337-z. 
10. Ribitsch I., Burk J., Delling U., et al. Basic science and clinical application of stem cells in veterinary medicine. Advances in Biochemical Engineering/Biotechnology. 2010;123:219–263. doi: 10.1007/10_2010_66. 
11. Sen B., Xie Z., Uzer G., et al. Intranuclear actin regulates osteogenesis. STEM CELLS. 2015;33(10):3065–3076. doi: 10.1002/stem.2090.
12. Brown S. G., Harman R. J., Black L. L. Adipose-derived stem cell therapy for severe muscle tears in working German shepherds: two case reports. Stem Cell Discovery. 2012;2(2):41–44. doi: 10.4236/scd.2012.22007. 
13. Levit R. D., Landázuri N., Phelps E. A., et al. Cellular encapsulation enhances cardiac repair. Journal of the American Heart Association. 2013;2(5)e000367
14. Lin B.-J., Wang J., Miao Y., et al. Cytokine loaded layer-by-layer ultrathin matrices to deliver single dermal papilla cells for spot-by-spot hair follicle regeneration. Journal of Materials Chemistry B. 2016;4(3):489–504. doi: 10.1039/c5tb02265g
15. Liang, Weishi, et al. "Mechanism of action of mesenchymal stem cell-derived exosomes in the intervertebral disc degeneration treatment and bone repair and regeneration." Frontiers in Cell and Developmental Biology9 (2022): 833840.
16. Benavides O. M., Brooks A. R., Cho S. K., Petsche Connell J., Ruano R., Jacot J. G. In situ vascularization of injectable fibrin/poly(ethylene glycol) hydrogels by human amniotic fluid-derived stem cells. Journal of Biomedical Materials Research Part A. 2015;103(8):2645–2653. doi: 10.1002/jbm.a.35402. 
17. Hosseini Mansoub N, Gurdal M, Karadadas E, et al. The role of PRP and adipose tissue-derived keratinocytes on burn wound healing in diabetic rats.Bioimpacts 2018;8:5-12. 10.15171/bi.2018.02
18. Srionrod N, Bootcha R, Petchdee S. Foal Deciduous Teeth Stem Cells Enhance Wound Healing in Rabbit Wound Model.The Thai Journal of Veterinary Medicine 2016;46:155-61.
19. Amirkhani MA, Shoae-Hassani A, Soleimani M, et al. Rejuvenation of facial skin and improvement in the dermal architecture by transplantation of autologous stromal vascular fraction: a clinical study.Bioimpacts 2016;6:149-54. 10.15171/bi.2016.21 
20. Scoville D. H., Sato T., He X. C., Li L. Current view: intestinal stem cells and signaling. 2008;134(3):849–864. doi: 10.1053/j.gastro.2008.01.079. 
21. Yin X., Farin H. F., Van Es J. H., Clevers H., Langer R., Karp J. M. Niche-independent high-purity cultures of Lgr5⁺ intestinal stem cells and their progeny. Nature Methods. 2014;11(1):106–112. doi: 10.1038/nmeth.2737.
22. Ksander B. R., Kolovou P. E., Wilson B. J., et al. ABCB5 is a limbal stem cell gene required for corneal development and repair.  2014;511(7509):353–357. doi: 10.1038/nature13426. 
23. Ahmad S. Concise review: limbal stem cell deficiency, dysfunction, and distress. Stem Cells Translational Medicine. 2012;1(2):110–115. doi: 10.5966/sctm.2011-0037. 
24. Fuoco C., Rizzi R., Biondo A., et al. In vivo generation of a mature and functional artificial skeletal muscle. EMBO Molecular Medicine. 2015;7(4):411–422. doi: 10.15252/emmm.201404062. 
25. Berry S. E. Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions. Stem Cells Translational Medicine. 2015;4(1):91–98. doi: 10.5966/sctm.2014-0060. 
26. Simon L., Ekman G. C., Kostereva N., et al. Direct transdifferentiation of stem/progenitor spermatogonia into reproductive and nonreproductive tissues of all germ layers. Stem Cells. 2009;27(7):1666–1675. doi: 10.1002/stem.93.
27. Cronk S. M., Kelly-Goss M. R., Ray H. C., et al. Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathy. Stem Cells Translational Medicine. 2015;4(5):459–467. doi: 10.5966/sctm.2014-0108. 
28. Ellis K. M., O'Carroll D. C., Lewis M. D., Rychkov G. Y., Koblar S. A. Neurogenic potential of dental pulp stem cells isolated from murine incisors. Stem Cell Research & Therapy. 2014;5, article 30 doi: 10.1186/scrt419. 
29. Acharya M. M., Martirosian V., Chmielewski N. N., et al. Stem cell transplantation reverses chemotherapy-induced cognitive dysfunction. Cancer Research. 2015;75(4):676–686. doi: 10.1158/0008-5472.CAN-14-2237.
30. Mizutari K., Fujioka M., Hosoya M., et al. Notch inhibition induces cochlear hair cell regeneration and recovery of hearing after acoustic trauma.  2013;77(1):58–69. doi: 10.1016/j.neuron.2012.10.032. 
31. Kuo B. R., Baldwin E. M., Layman W. S., Taketo M. M., Zuo J. In vivo cochlear hair cell generation and survival by coactivation of β-catenin and Atoh1. The Journal of Neuroscience. 2015;35(30):10786–10798. doi: 10.1523/jneurosci.0967-15.2015. 
32. Shaffiey S. A., Jia H., Keane T., et al. Intestinal stem cell growth and differentiation on a tubular scaffold with evaluation in small and large animals. Regenerative Medicine. 2016;11(1):45–61. doi: 10.2217/rme.15.70. 
33. Yang ZF, Ho DW, Ng MN, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell2008;13:153-66. 10.1016/j.ccr.2008.01.013
34. Soltysova A, Altanerova V, Altaner C. Cancer stem cells. Neoplasma2005;52:435.
35. P, et al. Identification of pancreatic cancer stem cells. Cancer Res2007;67:1030-7. 10.1158/0008-5472.CAN-06-2030
36. Fathi E, Farahzadi R. Enhancement of osteogenic differentiation of rat adipose tissue-derived mesenchymal stem cells by zinc sulphate under electromagnetic field via the PKA, ERK1/2 and Wnt/beta-catenin signaling pathways. PLoS One 2017;12:e0173877. 10.1371/journal.pone.0173877 
37. Sell S. Stem cells handbook. Springer, 2013. 
38. Greggio C., De Franceschi F., Figueiredo-Larsen M., et al. Artificial three-dimensional niches deconstruct pancreas development in vitro. 2013;140(21):4452–4462. doi: 10.1242/dev.096628
39. Ye L., Robertson M. A., Mastracci T. L., Anderson R. M. An insulin signaling feedback loop regulates pancreas progenitor cell differentiation during islet development and regeneration. Developmental Biology. 2016;409(2):354–369. doi: 10.1016/j.ydbio.2015.12.003. 
40. Potdar P. D., Jethmalani Y. D. Human dental pulp stem cells: applications in future regenerative medicine. World Journal of Stem Cells. 2015;7(5):839–851. doi: 10.4252/wjsc.v7.i5.839.
41. Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med1996;183:1797-806. 10.1084/jem.183.4.1797 
42. Trigg ME. Hematopoietic stem cells. Pediatrics2004;113:1051-7. 23. Seita J, Weissman IL. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med 2010;2:640-53. 10.1002/wsbm.86 
43. Mahla RS. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol 2016;2016
44. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell2001;105:369-77. 10.1016/S0092-8674(01)00328-2
45. potential of adult neural stem cells. Science2000;288:1660-3. 10.1126/science.288.5471.1660
46. Kalra K, Tomar P. Stem Cell: Basics, Classification and Applications. American Journal of Phytomedicine and Clinical Therapeutics2014;27:919-30. 
47. Kote Amol P, Pawar Sanjay D, Dhonde Satish M, et al. An overview of stem cell. Pharmacologyonline2011;3:1155-70. 
48. Levenberg S, Huang NF, Lavik E, et al. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci U S A2003;100:12741-6. 10.1073/pnas.1735463100 
49. Lu S-J, Li F, Vida L, et al. CD34+ CD38-hematopoietic precursors derived from human embryonic stem cells exhibit an embryonic gene expression pattern. Blood2004;103:4134-10.1182/blood-2003-10-3575
50. Rippon HJ, Bishop AE. Embryonic stem cells. Cell Prolif2004;37:23-34. 10.1111/j.1365-2184.2004.00298.x 
51. Birbrair A, Frenette PS. Niche heterogeneity in the bone marrow. Ann N Y Acad Sci2016;1370:82-96. 10.1111/nyas.13016